The 2022 Evonik Venture Capital is opening collaboration opportunities for start-ups with a focus on battery solutions. This initiative is aimed at creating multiple synergies with Evonik’s innovation activities and business lines active in battery materials and exploring investment opportunities with the Evonik Venture Capital unit.
More specifically, Evonik is planning to collaborate or invest in companies with a high level of differentiation and strong value proposition in the following areas
We are looking for start-ups offering additives applied to any of the battery components that will ultimately boost battery performances, processing capability, sustainability or thermal management. The process and chemistry associated with the fabrication of electrodes is also of high interest.
Additives can be under various forms: particles, polymers, liquids. All battery technologies are considered, from the more mature to the longer-term concepts.
Evonik would like to explore potential collaborations with start-ups working more specifically under the sustainability angle, offering additives that will facilitate the recycling and reuse of the battery materials. Sustainable binders for electrodes are important, as is critical metal recovery in battery recycling.
Evonik is also looking for investment opportunities in start-ups that can bring significant improvement in electrode fabrication process, explore new electrolytes or new cathode materials for non-cobalt batteries. Innovative battery architecture such as Lithium-metal is also of interest, as well as the digital approach where AI is used to enhance the battery performance.
They will introduce themselves, their interest and expectations in new collaborations. They will answer all your questions. Confirm your participation here.
Evonik is planning to collaborate and invest in companies offering high level of differentiation and strong value proposition.
To enter into the selection process, please fill in the application form, so your company can be introduced to Evonik team. We strongly encourage you to start your application form as soon as possible.
To guide you through the selection process, the Evonik Venture team will introduce you Evonik activities and Evonik Venture investment policy during an open web-meeting. The topic and interest of Evonik will be detailed.
Pre-selected companies will be invited to send a more detailed presentation. All applicants will receive feedback by BLUMORPHO team. Companies expressing their interest in collaborating with Evonik at late dates in the process might not have the time to be evaluated by the Evonik team.
Among the selected companies for collaboration, 15 will be invited to join the Internal Evonik Venture Capital Forum to introduce their activities to the Evonik Management and Business lines and to define collaboration roadmap during dedicated meetings.
Opportunity to engage with the Business Lines
All applications will be introduced to the Evonik Venture team in charge of the selection.
If your start-up is in the field of interest of Evonik, it is the right timing for you to get introduced to Evonik.
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €12.2 billion and an operating profit (adjusted EBITDA) of €1.91 billion in 2020. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. About 33,000 employees work together for a common purpose: We want to improve life today and tomorrow.
Evonik Venture Capital generates strategic value and growth opportunities through investing and partnering with innovative start-up companies. With a fund size of €250 million, Evonik Venture Capital has made about 40 investments since 2012, both direct and fund investments. The investment scope ranges from early stage to growth stage, with an investment volume of up to €15 million per portfolio company.
Evonik Venture Capital has offices in Germany, the USA and China and invests in innovative technologies and disruptive business models in the fields of Nutrition & Care, Specialty Additives and Smart Materials, as well as enabling digital technologies.
Head of Research Development & Innovation
REGISTER to our information webinar on the 22nd of February.